IBDEI0PL ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12549,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12549,1,1,0)
 ;;=1^V10.01
 ;;^UTILITY(U,$J,358.3,12549,1,8,0)
 ;;=8^Hx Of Tongue Malignancy
 ;;^UTILITY(U,$J,358.3,12549,2)
 ;;=^295203
 ;;^UTILITY(U,$J,358.3,12550,0)
 ;;=V10.02^^70^769^28
 ;;^UTILITY(U,$J,358.3,12550,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12550,1,1,0)
 ;;=1^V10.02
 ;;^UTILITY(U,$J,358.3,12550,1,8,0)
 ;;=8^Hx-Oral/Pharynx Malg Nec
 ;;^UTILITY(U,$J,358.3,12550,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,12551,0)
 ;;=V10.22^^70^769^27
 ;;^UTILITY(U,$J,358.3,12551,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12551,1,1,0)
 ;;=1^V10.22
 ;;^UTILITY(U,$J,358.3,12551,1,8,0)
 ;;=8^Hx-Nose/Ear/Sinus Malig
 ;;^UTILITY(U,$J,358.3,12551,2)
 ;;=^295215
 ;;^UTILITY(U,$J,358.3,12552,0)
 ;;=V10.11^^70^769^14
 ;;^UTILITY(U,$J,358.3,12552,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12552,1,1,0)
 ;;=1^V10.11
 ;;^UTILITY(U,$J,358.3,12552,1,8,0)
 ;;=8^Hx-Bronchogenic Malignan
 ;;^UTILITY(U,$J,358.3,12552,2)
 ;;=^295211
 ;;^UTILITY(U,$J,358.3,12553,0)
 ;;=V10.12^^70^769^33
 ;;^UTILITY(U,$J,358.3,12553,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12553,1,1,0)
 ;;=1^V10.12
 ;;^UTILITY(U,$J,358.3,12553,1,8,0)
 ;;=8^Hx-Tracheal Malignancy
 ;;^UTILITY(U,$J,358.3,12553,2)
 ;;=^295212
 ;;^UTILITY(U,$J,358.3,12554,0)
 ;;=V10.21^^70^769^21
 ;;^UTILITY(U,$J,358.3,12554,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12554,1,1,0)
 ;;=1^V10.21
 ;;^UTILITY(U,$J,358.3,12554,1,8,0)
 ;;=8^Hx-Laryngeal Malignancy
 ;;^UTILITY(U,$J,358.3,12554,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,12555,0)
 ;;=V10.29^^70^769^20
 ;;^UTILITY(U,$J,358.3,12555,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12555,1,1,0)
 ;;=1^V10.29
 ;;^UTILITY(U,$J,358.3,12555,1,8,0)
 ;;=8^Hx-Intrathoracic Mal Nec
 ;;^UTILITY(U,$J,358.3,12555,2)
 ;;=^295216
 ;;^UTILITY(U,$J,358.3,12556,0)
 ;;=V10.87^^70^769^12
 ;;^UTILITY(U,$J,358.3,12556,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12556,1,1,0)
 ;;=1^V10.87
 ;;^UTILITY(U,$J,358.3,12556,1,8,0)
 ;;=8^Hx Of Thyroid Malignancy
 ;;^UTILITY(U,$J,358.3,12556,2)
 ;;=^295245
 ;;^UTILITY(U,$J,358.3,12557,0)
 ;;=V10.51^^70^769^1
 ;;^UTILITY(U,$J,358.3,12557,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12557,1,1,0)
 ;;=1^V10.51
 ;;^UTILITY(U,$J,358.3,12557,1,8,0)
 ;;=8^Hx Of Bladder Malignancy
 ;;^UTILITY(U,$J,358.3,12557,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,12558,0)
 ;;=V10.52^^70^769^9
 ;;^UTILITY(U,$J,358.3,12558,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12558,1,1,0)
 ;;=1^V10.52
 ;;^UTILITY(U,$J,358.3,12558,1,8,0)
 ;;=8^Hx Of Kidney Malignancy
 ;;^UTILITY(U,$J,358.3,12558,2)
 ;;=^295229
 ;;^UTILITY(U,$J,358.3,12559,0)
 ;;=V10.46^^70^769^29
 ;;^UTILITY(U,$J,358.3,12559,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12559,1,1,0)
 ;;=1^V10.46
 ;;^UTILITY(U,$J,358.3,12559,1,8,0)
 ;;=8^Hx-Prostatic Malignancy
 ;;^UTILITY(U,$J,358.3,12559,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,12560,0)
 ;;=V10.47^^70^769^32
 ;;^UTILITY(U,$J,358.3,12560,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12560,1,1,0)
 ;;=1^V10.47
 ;;^UTILITY(U,$J,358.3,12560,1,8,0)
 ;;=8^Hx-Testicular Malignancy
 ;;^UTILITY(U,$J,358.3,12560,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,12561,0)
 ;;=V10.49^^70^769^23
 ;;^UTILITY(U,$J,358.3,12561,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12561,1,1,0)
 ;;=1^V10.49
 ;;^UTILITY(U,$J,358.3,12561,1,8,0)
 ;;=8^Hx-Male Genit Malig Nec
 ;;^UTILITY(U,$J,358.3,12561,2)
 ;;=^295226
 ;;^UTILITY(U,$J,358.3,12562,0)
 ;;=V10.45^^70^769^24
 ;;^UTILITY(U,$J,358.3,12562,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12562,1,1,0)
 ;;=1^V10.45
 ;;^UTILITY(U,$J,358.3,12562,1,8,0)
 ;;=8^Hx-Male Genit Malig Nos
